News

Author: Benjamin Dyhre

Download Our Investor Presentation

Download our presentation

Download presentation

"*" indicates required fields

Calluna Pharma will use the contact details you provide to contact you with regards to offering further information, as well as to keep you updated on our latest developments. You may unsubscribe at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, please review our Privacy Policy.

Latest news

Latest News Press Releases
Calluna Pharma Completes Enrollment in Phase 2 AURORA Study of CAL101 for Idiopathic Pulmonary Fibrosis (IPF)

Study of CAL101, which targets a novel upstream pathway implicated in fibrotic disease, enrolls 161 patients more than six months ahead of plan;...

Read more
Calluna Pharma Highlighted in a New BioCentury IPF Article

Idiopathic pulmonary fibrosis (IPF) is entering an important new chapter, as highlighted in a newly published BioCentury article that underscores...

Read more